LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 60 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,797,250 | -31.6% | 455,000 | -45.8% | 0.01% | -37.5% |
| Q2 2023 | $2,626,070 | +27.4% | 839,000 | +84.4% | 0.01% | +33.3% |
| Q1 2023 | $2,061,150 | +5.1% | 455,000 | -4.2% | 0.01% | -14.3% |
| Q4 2022 | $1,961,750 | +29.1% | 475,000 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $1,520,000 | -28.5% | 475,000 | +141.2% | 0.01% | -25.0% |
| Q4 2021 | $2,125,000 | -6.4% | 196,896 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $2,270,000 | +133.1% | 196,896 | +98.6% | 0.01% | +150.0% |
| Q2 2021 | $974,000 | +286.5% | 99,160 | +474.5% | 0.00% | +300.0% |
| Q1 2021 | $252,000 | -31.9% | 17,260 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $370,000 | +41.2% | 17,260 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $262,000 | +18.0% | 17,260 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $222,000 | – | 17,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,414,468 | $8,720,383 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $53,026,447 | 1.13% |
| Opaleye Management Inc. | 1,390,000 | $4,350,700 | 1.04% |
| DAFNA Capital Management LLC | 350,373 | $1,096,667 | 0.30% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $2,522,201 | 0.18% |
| Atlas Venture Advisors, Inc. | 292,184 | $914,536 | 0.16% |
| Verition Fund Management LLC | 2,716,713 | $8,503,312 | 0.11% |
| Woodline Partners LP | 1,681,913 | $5,264,388 | 0.06% |
| Fi3 FINANCIAL ADVISORS, LLC | 25,548 | $79,965 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 363,505 | $1,137,771 | 0.04% |